Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × cobimetinib × Tumor-Agnostic × Clear all

Phase

Status

Completed 4 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3 Other hematologic neoplasm 3 Lymphoid 3 Thoracic 2 Sarcoma 2 Myeloid 2 Head & Neck 2 Gynecologic 2 Gastrointestinal 2 Endocrine 2 Dermatologic 2 Tumor-Agnostic 1 CNS 1

Conditions

Interventions

pembrolizumab 22 Specimen Handling 18 Magnetic Resonance Spectroscopy 16 Blood Specimen Collection 16 Biopsy 14 Standard of Care 8 Radiosurgery 8 atezolizumab 7 Surveys and Questionnaires 7 Radiotherapy 7 Gemcitabine 7 Cisplatin 7 Paclitaxel 6 Nivolumab 6 Fluorouracil 6 Carboplatin 6 Palliative Care 5 Irinotecan 5 Interviews as Topic 5 Drug Therapy 5 Docetaxel 5 Cyclophosphamide 5 Bevacizumab 5 fludarabine 4 durvalumab 4 Taxes 4 Surgical Procedures, Operative 4 Oxaliplatin 4 Observation 4 Leucovorin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04341181 2025-07-25

ProTarget

Rigshospitalet, Denmark

Phase 2 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡